Biotech · Private company
Arrevus Inc.
Track this companyFree. Adds Arrevus Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- linezolidPhase 3 · Acute Bacterial Skin and Skin Structure InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- sodium fusidatePhase 3 · Acute Bacterial Skin and Skin Structure InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- sodium fusidatePhase 3 · Refractory Bone or Joint InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- CEM-102Phase 2 · Skin Diseases, BacterialClinicalTrials.gov · fetched Nov 12, 2026
- CEM-102Phase 2 · Prosthetic Joint Infections of HipClinicalTrials.gov · fetched Nov 12, 2026
- LinezolidPhase 2 · Skin Diseases, BacterialClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 2 · Prosthetic Joint Infections of HipClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint InfectionsPHASE2_PHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02569541 · fetched Nov 12, 2026
- Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsPHASE3 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02570490 · fetched Nov 12, 2026
- Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer InfectionPHASE2 · TERMINATED · started Dec 1, 2012ClinicalTrials.gov NCT01756924 · fetched Nov 12, 2026
- Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin InfectionsPHASE2 · COMPLETED · started Aug 1, 2009ClinicalTrials.gov NCT00948142 · fetched Nov 12, 2026